Axsome Therapeutics Inc. (AXSM)
NASDAQ
Closed
Oct 8, 2026
Day's Range
166.2152 wk Range
117.30Overview - AXSM - Axsome Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
9.29B
P/E (Trailing)
‪-48.69‬
P/E (Forward)
‪35.60‬
PEG Ratio
‪-23.61‬
Price / Sales (TTM)
‪12.09‬
Price / Book
‪112.52‬
EV / EBITDA
‪-53.74‬
Profitability
Gross Margin
‪93.78%‬
Profit Margin
‪-24.67%‬
Operating Margin
‪-23.41%‬
Return on Assets
‪-16.31%‬
Return on Equity
‪-245.10%‬
Ownership
Shares Outstanding
52.29M
Float
44.46M
Short % of Shares Outstanding
‪9.29%‬
Held by Insiders
‪15.08%‬
Held by Institutions
‪74.64%‬
Price stats
Beta
‪0.70‬
50-Day Avg
‪210.66‬
200-Day Avg
‪199.62‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
22 analysts
Average price target
‪$ 285.42‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AXSM - Axsome Therapeutics Inc.
Peers - AXSM - Axsome Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- AXSMNASDAQAxsome Therapeutics Inc.9.37BMarket Cap+33.09%52-week change-48.69P/E (Trailing)‪-24.67%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - AXSM - Axsome Therapeutics Inc.
About
Axsome Therapeutics Inc. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system disorders. Its marketed products include Auvelity for major depressive disorder, Sunosi for excessive daytime sleepiness related to narcolepsy or obstructive sleep apnea, and Symbravo…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
